✦ LIBER ✦

EFFECT OF CONIVAPTAN, A COMBINED VASOPRESSIN V1a AND V2 RECEPTOR ANTAGONIST, ON VASOPRESSIN-INDUCED CARDIAC AND HAEMODYNAMIC CHANGES IN ANAESTHETISED DOGS

✍ Scribed by TAKEYUKI YATSU; TOSHIYUKI KUSAYAMA; YUICHI TOMURA; YUKINORI ARAI; MOTONORI AOKI; ATSUO TAHARA; KOH-ICHI WADA; JUNKO TSUKADA

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cardiovascular and renal effects of coni

✍ Takeyuki Yatsu; Yuichi Tomura; Atsuo Tahara; Koh-ichi Wada; Toshiyuki Kusayama; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 466 KB

Acute hemodynamic effects of conivaptan,

✍ J.E. Udelson; W.B. Smith; G.H. Hendrix 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 33 KB

Pharmacological profile of YM087, a nove

✍ Takeyuki Yatsu; Yuichi Tomura; Atsuo Tahara; Koh-ichi Wada; Junko Tsukada; Watar 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 258 KB

Pharmacokinetic and pharmacodynamic effe

✍ M. Burnier; A. F. Fricker; D. Hayoz; J. Nussberger; H. R. Brunner 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 110 KB

Effects of YM218, a nonpeptide vasopress

✍ Atsuo Tahara; Junko Tsukada; Yuichi Tomura; Toshiyuki Kusayama; Koh-ichi Wada; N 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 311 KB

Novel Vasopressin V1A and V2 Antagonist

✍ Joseph G. Verbalis; Joseph G. Bisaha; Neila Smith 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 58 KB